Literature DB >> 17998148

Hepatitis C virus core protein impairs in vitro priming of specific T cell responses by dendritic cells and hepatocytes.

Mona Zimmermann1, Christin Flechsig, Nicola La Monica, Marco Tripodi, Guido Adler, Nektarios Dikopoulos.   

Abstract

BACKGROUND/AIMS: Hepatitis C virus leads to chronic hepatitis in the majority of infected individuals. The mechanism of viral persistence is not completely understood. Hepatitis C virus core protein is produced within hepatocytes and is secreted during HCV infection. Our study characterizes the effects of core protein on T cell priming in mice.
METHODS: We used a system of antigen-specific in vitro priming of CD4(+) and CD8(+) T cells by myeloid dendritic cells, hepatoma cells or primary hepatocytes. Core protein was either added to the cultures or expressed by antigen-presenting cells.
RESULTS: Antigen-presenting cells treated with core protein showed reduced surface expression of major histocompatibility molecules. Myeloid dendritic cells showed also reduced expression of costimulatory molecules. CD4(+) and CD8(+) T cells primed by these cells showed defects in activation, proliferation, and cytokine production. Importantly, CD4(+) and also CD8(+) T cells primed in the presence of core protein showed an increase in interleukin-10 production resembling the phenotype of regulatory T cells.
CONCLUSIONS: Hepatitis C virus core protein inhibits priming of antigen-specific CD4(+) and CD8(+) T cell responses by downregulation of major histocompatibility molecules and costimulatory molecules on antigen-presenting cells and induces development of IL-10-producing T cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17998148     DOI: 10.1016/j.jhep.2007.08.008

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  18 in total

1.  HCV J6/JFH1 tilts the capability of myeloid-derived dendritic cells to favor the induction of immunosuppression and Th17-related inflammatory cytokines.

Authors:  Zhong Fang; Kai Zhu; Nining Guo; Na Zhang; Mo Guan; Chunfu Yang; Qinsong Pan; Ruicheng Wei; Chunhui Yang; Chaoyang Deng; Xiaoqing Liu; Ping Zhao; Qibin Leng
Journal:  Pharm Res       Date:  2013-04-26       Impact factor: 4.200

2.  Chronic ethanol diet increases regulatory T-cell activity and inhibits hepatitis C virus core-specific cellular immune responses in mice.

Authors:  Vivian Ortiz; Jack R Wands
Journal:  Hepatol Res       Date:  2013-07-04       Impact factor: 4.288

Review 3.  Immunopathogenesis of Hepatitis C Virus Infection.

Authors:  David E Kaplan
Journal:  Gastroenterol Clin North Am       Date:  2015-08-13       Impact factor: 3.806

4.  Inhibition of the HCV core protein on the immune response to HBV surface antigen and on HBV gene expression and replication in vivo.

Authors:  Wenbo Zhu; Chunchen Wu; Wanyu Deng; Rongjun Pei; Yun Wang; Liang Cao; Bo Qin; Mengji Lu; Xinwen Chen
Journal:  PLoS One       Date:  2012-09-14       Impact factor: 3.240

5.  Investigations of the functional states of dendritic cells under different conditioned microenvironments by Fourier transformed infrared spectroscopy.

Authors:  Rong Dong; Jinhua Long; Xiaoli Xu; Chunlin Zhang; Zongyao Wen; Long Li; Weijuan Yao; Zhu Zeng
Journal:  Biomed Eng Online       Date:  2014-01-10       Impact factor: 2.819

6.  Development of an in vitro assay and demonstration of Plasmodium berghei liver-stage inhibition by TRAP-specific CD8+ T cells.

Authors:  Rhea J Longley; Karolis Bauza; Katie J Ewer; Adrian V S Hill; Alexandra J Spencer
Journal:  PLoS One       Date:  2015-03-30       Impact factor: 3.240

7.  Hepatitis C virus-mediated inhibition of cathepsin S increases invariant-chain expression on hepatocyte surface.

Authors:  Hangeun Kim; Budhaditya Mazumdar; Sandip K Bose; Keith Meyer; Adrian M Di Bisceglie; Daniel F Hoft; Ranjit Ray
Journal:  J Virol       Date:  2012-07-03       Impact factor: 5.103

8.  Construction and preparation of three recombinant adenoviruses expressing truncated NS3 and core genes of hepatitis C virus for vaccine purposes.

Authors:  Seyed Younes Hosseini; Farzaneh Sabahi; Seyed Mohammad Moazzeni; Mohammad Hossein Modarressi; Mehdi Saberi Firoozi; Mehrdad Ravanshad
Journal:  Hepat Mon       Date:  2012-08-14       Impact factor: 0.660

Review 9.  Immunotherapy for liver tumors: present status and future prospects.

Authors:  Pablo Matar; Laura Alaniz; Viviana Rozados; Jorge B Aquino; Mariana Malvicini; Catalina Atorrasagasti; Manuel Gidekel; Marcelo Silva; O Graciela Scharovsky; Guillermo Mazzolini
Journal:  J Biomed Sci       Date:  2009-03-06       Impact factor: 8.410

Review 10.  Success of antiviral therapy in chronic hepatitis C infection relates to functional status of myeloid dendritic cells.

Authors:  Deepa Rana; Yogesh Chawla; Sunil K Arora
Journal:  Indian J Med Res       Date:  2013-11       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.